IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 354 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH LETTER

Counterfeit and substandard quality of drugs: The need for an effective and stringent regulatory control in India and other developing countries

Khan Azhar Yaqoob, Ghilzai Naushad M. Khan

Year : 2007| Volume: 39| Issue : 4 | Page no: 206-207

   This article has been cited by
 
1 Development and validation of a UPLC method for screening potentially counterfeit anti-hypertensive drugs using design of experiment
Chiguru Vishnuvardhan,R. Srinivas,N. Satheeshkumar
Analytical Methods. 2014; 6(13): 4610
[Pubmed]  [Google Scholar] [DOI]
2 Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: A single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers
Muzaffar Iqbal, Arshad Khuroo, Lakhvinder S. Batolar, Monika Tandon, Tausif Monif, P.L. Sharma
Clinical Therapeutics. 2010; 32(3): 588
[HTML Full text]  [Google Scholar] [DOI]
3 Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia
Mohiuddin Hussain Khan, Junko Okumura, Tey Sovannarith, Nam Nivanna, Manabu Akazawa, Kazuko Kimura
Tropical Medicine & International Health. 2010; 15(5): 639-644
[Pubmed]  [Google Scholar] [DOI]
4 The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India : Counterfeit drugs in developing countries
M. Seear, D. Gandhi, R. Carr, A. Dayal, D. Raghavan, N. Sharma
Journal of Clinical Pharmacy and Therapeutics. 2010; : no
[HTML Full text]  [Google Scholar] [DOI]
5 Travelling to India for the Delhi XIX Commonwealth Games 2010
Marc T.M. Shaw, Peter A. Leggat, Santanu Chatterjee
Travel Medicine and Infectious Disease. 2010; 8(3): 129
[HTML Full text]  [Google Scholar] [DOI]
6 Regulatory status of banned drugs in India
Shaji, J., Lodha, S.
Indian Journal of Pharmaceutical Education and Research. 2010; 44(1): 86-94
[Pubmed]  [Google Scholar]
7 Post-market in vitro bioequivalence study of six brands of ciprofloxacin tablets/caplets in Jos, Nigeria
Ngwuluka, N.C., Lawal, K., Olorunfemi, P.O., Ochekpe, N.A.
Scientific Research and Essays. 2009; 4(4): 298-305
[Pubmed]  [Google Scholar]
8 Counterfeit and substandard drugs: The need for an effective and stringent regulatory control in India and other developing countries [1]
Sukhlecha, A.
Indian Journal of Pharmacology. 2007; 39(5): 255
[Pubmed]  [Google Scholar]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow